urea has been researched along with Polycystic Ovary Syndrome in 2 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The rats with polycystic ovary syndrome (PCOS) that were induced by Letrozole exhibited increased levels of urea and creatinine." | 8.31 | Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome. ( Boyina, R; Bukke, SPN; Hussaini, B; Karumanchi, SK; Manchikalapati, B; Marri, J; Odoma, S; Pathange, BBR; Rachamsetty, K, 2023) |
| " The rats with polycystic ovary syndrome (PCOS) that were induced by Letrozole exhibited increased levels of urea and creatinine." | 4.31 | Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome. ( Boyina, R; Bukke, SPN; Hussaini, B; Karumanchi, SK; Manchikalapati, B; Marri, J; Odoma, S; Pathange, BBR; Rachamsetty, K, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukke, SPN | 1 |
| Pathange, BBR | 1 |
| Karumanchi, SK | 1 |
| Marri, J | 1 |
| Boyina, R | 1 |
| Rachamsetty, K | 1 |
| Manchikalapati, B | 1 |
| Odoma, S | 1 |
| Hussaini, B | 1 |
| Lainas, TG | 1 |
| Sfontouris, IA | 1 |
| Zorzovilis, IZ | 1 |
| Petsas, GK | 1 |
| Lainas, GT | 1 |
| Iliadis, GS | 1 |
| Kolibianakis, EM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| GnRH Antagonist in the Luteal Phase Compared to Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) in Whom All Embryos Are Cryopreserved[NCT02392520] | 40 participants (Anticipated) | Interventional | 2015-05-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for urea and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol.
Topics: Adult; Blastocyst; Chorionic Gonadotropin; Combined Modality Therapy; Cryopreservation; Estradiol; F | 2009 |
1 other study available for urea and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome.
Topics: Animals; Blood Glucose; Cholesterol; Creatinine; Estrogens; Female; Humans; Letrozole; Menstruation | 2023 |